Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Colossal Biosciences

Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.

Overview Structured Data Issues Contributors Activity

colossal.com

Is a

Company

Organization

Company attributes

Industry

Location

CEO

Pitchbook URL

pitchbook.com/profiles...481220-47

Legal Name

Colossal Biosciences Inc.0

Number of Employees (Ranges)

51 – 2000

Email Address

pr@colossal.com

info@colossal.com

Number of Employees

870

Full Address

1401 Lavaca St, Unit #155 Austin, TX 78701, United States0

Investors

‌

First Light Capital Group

...

Total Funding Amount (USD)

260,000,000

Latest Funding Round Date

January 17, 2025

Latest Funding Type

Series C

COO

‌

Kent Wakeford (entrepreneur)

Technologies Used

CRISPR

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

200,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Colossal Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API